West Pharmaceutical stock heads into the open after a 2.6 percent gain
Published on 09/25/2026 at 04:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
West Pharmaceutical stock traded at USD 375.97 on the Nasdaq on September 23, 2026, 2.6 percent below its 52-week high. The latest dated market report placed the stock near that level as US equities later finished mixed on September 24, 2026.
September 23, 2026 in numbers
West Pharmaceutical Services (ISIN US9523901012) traded at USD 375.97 on September 23, 2026, according to the dated market report. The same report put the shares 2.6 percent below their 52-week high, providing a quantified comparison with the recent peak.
As Ad Hoc News reported on September 24, 2026, the stock had gained after a target increase, while its quoted September 23 level remained below the 52-week high.
September 25, 2026 market setting
The S&P 500 closed at 7,704.13 on September 24, 2026, down 1.90 points, while the Nasdaq Composite rose 3.34 points to 26,939.37. The mixed index performance provides the latest dated US market context ahead of the next session.
As ABC News reported on September 24, 2026, the Dow Jones Industrial Average fell 0.3 percent, while the Nasdaq Composite was nearly unchanged on the session.
